World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03183076
Date of registration: 31/05/2017
Prospective Registration: No
Primary sponsor: Instituto Mexicano del Seguro Social
Public title: Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy
Scientific title: Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy in Adults Patients
Date of first enrolment: September 1, 2015
Target sample size: 14
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03183076
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Investigator).  
Phase:  N/A
Countries of recruitment
Mexico
Contacts
Name:     MarĂ­a I Alanis
Address: 
Telephone:
Email:
Affiliation:  Instituto Mexicano del Seguro Social
Key inclusion & exclusion criteria

Inclusion Criteria:

- Minimum age of 18 years

- Patients that meet the criteria of drug-resistant epilepsy

- Patients treated with Rational polytherapy, a minimum of 6 months, with no changes in
their drug refractory condition.

- Patients with drug- resistant epilepsy with informed consent signed by themselves and
their proxy.

- Patients with drug-resistant epilepsy of any etiology, except tumor, metabolic,
degenerative or progressive.

Exclusion Criteria:

- Patients with drug-resistant epilepsy simultaneous alternate treatment to the Atkins
Diet modified.

- Patients with a neurological entity progressive and fatal

- Patients with congenital diseases and difficulty to metabolize fats or that require
high amounts of carbohydrates in the diet.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Epilepsy, Drug Resistant
Intervention(s)
Drug: Pharmacotherapy without diet
Other: modified adkins diet
Primary Outcome(s)
Frequency of epileptic seizures [Time Frame: 3 months]
Secondary Outcome(s)
Blood chemistry (serum electrolytes) [Time Frame: 3 months]
Blood tests (Hematic biometry) [Time Frame: 3 months]
ketonuria [Time Frame: 3 months]
Measurement of quality of life and decrease in seizures [Time Frame: 3 months]
liver function tests [Time Frame: 3 months]
Therapeutic response observed in electroencephalogram [Time Frame: 3 months]
Secondary ID(s)
F2016-1301-72
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history